The significant increase in the phosphorylation of p38, ERK and NF-κB p65, observed after the treatment with RA patient EMVs, suggests that these vesicles carry bioactive molecules capable of potent immune activation, potentially contributing to the chronic inflammation observed in RA (41). The gene discussed is NFKB1; the disease is rheumatoid arthritis.